US Biopharmaceutical Company Liminatus Pharma Plans to Raise $500 Million to Invest in BNB
BlockBeats News, July 28th, According to a report by businessinsider, Clinical-stage biopharmaceutical company Liminatus Pharma, Inc. (NASDAQ: LIMN) today announced plans to strategically expand into the cryptocurrency and blockchain space.
The company plans to establish a subsidiary named "American BNB Strategy" to lead its digital asset investment and management plan. Through this platform, Liminatus plans to gradually raise and deploy up to $500 million in funds, with the goal of strategically long-term investing in BNB.
Liminatus emphasized that while the company remains fully committed to its core business - advancing cancer treatments and pancreatic cancer diagnostic technologies, expanding into the digital asset space is seen as a necessary step to support long-term growth and enhance shareholder value.
Liminatus is a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer patients. The company is advancing a series of novel therapies targeting cancer antigens and tumor-specific immune responses.
You may also like

How to capture the next Alpha in the narrative of predictive markets?

"Legal" Ponzi scheme? Unveiling the circular lending of Gemini exchange and its founder

The first stock of stablecoins, Circle, has officially launched the new public chain ARC points system, and the interactive guide is here

Oil prices are approaching a critical point. What will happen in mid-April?

The oil price is approaching a critical point, what will happen in mid-April?

Mechanism drives value, deflation leads the future: MIAU will officially launch on PancakeSwap on April 13

Zhou Hang, the founder of Yidao Yongche: Cryptocurrency has finally arrived at its time to shine

Who else cannot be distilled into skill?

Who else cannot be distilled into skill?

The huge shock in the South Korean cryptocurrency market: How should traders view it?

From "Kimchi Premium" to Bithumb's Rectification: An Interpretation of the Current Situation in the South Korean Crypto Market

How to Automate Your Workflow with AI (No Code Required)

Conversation with Pantera Founder: Bitcoin Has Reached Escape Velocity, Traditional Assets Are Being Left Behind

Is it still worth buying Circle on the callback?

BIT Launches Landmark "Same Name Virtual Account" Feature: Ushering in a New Era of OTC Trading that is Convenient, Efficient, and Compliant

Further Oracle Integration Reveals Polymarket's Ambitions

CoinGlass: 2026 Q1 Cryptocurrency Market Share Research Report

